| South County Nursing Home Inc | |
| 1101 West Outer 21 Road, Arnold, Missouri 63010 | |
| (636) 296-5455 | |
| Name | South County Nursing Home Inc |
|---|---|
| Location | 1101 West Outer 21 Road, Arnold, Missouri |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 153 |
| Occupancy Rate | 45.16% |
| Medicare ID (CCN) | 265509 |
| Legal Business Name | South County Nursing Home, Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1649312745 |
| Organization Name | SOUTH COUNTY NURSING HOME, INC. |
| Address | 1101 W Outer 21 Rd, Arnold, MO 63010 |
| Phone Number | 636-296-5455 |
News Archive
Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.
For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.
Minnesota Gov. Mark Dayton sent letters to HHS Sec. Kathleen Sebelius and Republican leaders in his state Tuesday saying that he is moving forward with implementing the health law - including the formation of a health insurance exchange - even though GOP leaders there are in a holding pattern.
Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, is pleased to announce that the company has been awarded $245,000, the maximum amount given for a grant under the US Qualifying Therapeutic Discovery Project (QTDP) Program.
Mexican-American children who show evidence of greater adaptation into American culture face significantly higher odds of being at high risk for Type 2 diabetes than those who do not similarly adapt, according to a University of North Texas Health Science Center study.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.
For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.
Minnesota Gov. Mark Dayton sent letters to HHS Sec. Kathleen Sebelius and Republican leaders in his state Tuesday saying that he is moving forward with implementing the health law - including the formation of a health insurance exchange - even though GOP leaders there are in a holding pattern.
Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, is pleased to announce that the company has been awarded $245,000, the maximum amount given for a grant under the US Qualifying Therapeutic Discovery Project (QTDP) Program.
Mexican-American children who show evidence of greater adaptation into American culture face significantly higher odds of being at high risk for Type 2 diabetes than those who do not similarly adapt, according to a University of North Texas Health Science Center study.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 12.82 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 0.79 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 5.56 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.08 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.56 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.35 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 36.7 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |